======= SH3PXD2B ======= == Gene Information == * **Official Symbol**: SH3PXD2B * **Official Name**: SH3 and PX domains 2B * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=285590|285590]] * **UniProt**: [[https://www.uniprot.org/uniprot/A1X283|A1X283]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SH3PXD2B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SH3PXD2B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/613293|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes an adapter protein that is characterized by a PX domain and four Src homology 3 domains. The encoded protein is required for podosome formation and is involved in cell adhesion and migration of numerous cell types. Mutations in this gene are the cause of Frank-ter Haar syndrome (FTHS), and also Borrone Dermato-Cardio-Skeletal (BDCS) syndrome. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015]. * **UniProt Summary**: Adapter protein involved in invadopodia and podosome formation and extracellular matrix degradation. Binds matrix metalloproteinases (ADAMs), NADPH oxidases (NOXs) and phosphoinositides. Acts as an organizer protein that allows NOX1- or NOX3-dependent reactive oxygen species (ROS) generation and ROS localization. Plays a role in mitotic clonal expansion during the immediate early stage of adipocyte differentiation (By similarity). {ECO:0000250, ECO:0000269|PubMed:12615925, ECO:0000269|PubMed:19755710, ECO:0000269|PubMed:20609497}. |SH3 2| |SH3 1| |PX| |regulation of brood size| |osteoblast fate commitment| |podosome assembly| |positive regulation of adipose tissue development| |regulation of adipose tissue development| |superoxide-generating NADPH oxidase activator activity| |phosphatidylinositol-5-phosphate binding| |phosphatidylinositol-3,5-bisphosphate binding| |podosome| |phosphatidylinositol-4-phosphate binding| |positive regulation of multicellular organism growth| |SH2 domain binding| |adipose tissue development| |superoxide metabolic process| |phosphatidylinositol-3-phosphate binding| |positive regulation of stress fiber assembly| |positive regulation of fat cell differentiation| |positive regulation of actin filament bundle assembly| |extracellular matrix disassembly| |regulation of multicellular organism growth| |cranial skeletal system development| |regulation of stress fiber assembly| |phosphatidylinositol binding| |regulation of actomyosin structure organization| |regulation of actin filament bundle assembly| |cell projection| |reactive oxygen species metabolic process| |regulation of fat cell differentiation| |osteoblast differentiation| |positive regulation of developmental growth| |positive regulation of supramolecular fiber organization| |bone development| |multi-multicellular organism process| |positive regulation of cytoskeleton organization| |connective tissue development| |skeletal system morphogenesis| |cell fate commitment| |positive regulation of growth| |regulation of actin filament organization| |ossification| |regulation of developmental growth| |extracellular matrix organization| |regulation of actin cytoskeleton organization| |regulation of supramolecular fiber organization| |eye development| |visual system development| |sensory system development| |extracellular structure organization| |regulation of actin filament-based process| |cellular component disassembly| |protein localization to membrane| |skeletal system development| |positive regulation of cellular component biogenesis| |heart development| |regulation of cytoskeleton organization| |sensory organ development| |cell junction| |positive regulation of organelle organization| |regulation of growth| |organelle assembly| |multicellular organismal reproductive process| |multicellular organism reproduction| |circulatory system development| |animal organ morphogenesis| |regulation of cellular component biogenesis| |positive regulation of cell differentiation| |multi-organism reproductive process| |positive regulation of cellular component organization| |regulation of organelle organization| |positive regulation of developmental process| |reproductive process| |reproduction| |positive regulation of catalytic activity| |protein-containing complex assembly| |cellular protein localization| |cellular macromolecule localization| |positive regulation of multicellular organismal process| |tissue development| |positive regulation of molecular function| |regulation of cell differentiation| |protein-containing complex subunit organization| |positive regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp58|UM131593 0.1μM R01 exp58]]|-1.74| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11168 * **Expression level (log2 read counts)**: 2.31 {{:chemogenomics:nalm6 dist.png?nolink |}}